| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.9M | +1.3% |
| R&D Expense | $1.6M | -4.2% |
| SG&A Expense | $3.3M | +3.7% |
| Operating Income | -$1.3M | -10.8% |
| Interest Expense | $6.3M | -30.0% |
| Pre-tax Income | -$6.0M | +40.1% |
| Net Income | -$6.0M | +40.1% |
| EPS (Basic) | -$0.04 | +42.9% |
| EPS (Diluted) | -$0.04 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $520K | -21.1% |
| Accounts Receivable | $948K | +1.6% |
| Inventory | $301K | -13.7% |
| Current Assets | $1.8M | -15.4% |
| Total Assets | $3.9M | -22.3% |
| Current Liabilities | $66.1M | -26.0% |
| Total Liabilities | $80.6M | -31.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$370K | -154.5% |
| Capital Expenditures | $5K | -94.8% |
| Investing Cash Flow | -$5K | +97.7% |
| Financing Cash Flow | $236K | +257.5% |
| Free Cash Flow | -$375K | -164.8% |
| +42.9% |
| Stockholders' Equity |
| -$76.7M |
| +32.0% |